Karcinom plic (Czech Wikipedia)

Analysis of information sources in references of the Wikipedia article "Karcinom plic" in Czech language version.

refsWebsite
Global rank Czech rank
4th place
8th place
2nd place
4th place
1st place
1st place
1,389th place
341st place
1,684th place
3,086th place
195th place
168th place
6th place
10th place
222nd place
83rd place
4,025th place
1,769th place
8th place
28th place
low place
low place
6,464th place
1,959th place
low place
low place
low place
low place
234th place
72nd place
613th place
692nd place
low place
5,798th place
218th place
304th place
low place
low place
low place
low place
882nd place
880th place
3,680th place
2,061st place
838th place
436th place
8,869th place
8,116th place
2,374th place
1,252nd place
610th place
203rd place
low place
8,142nd place
low place
low place
97th place
111th place
low place
low place
1,903rd place
5,340th place
low place
low place
1,226th place
800th place
low place
low place
5th place
3rd place
low place
low place

aacrjournals.org

cancerres.aacrjournals.org

  • CHENG, YW, Chiou HL, Sheu GT et al. The association of human papillomavirus 16/18 infection with lung cancer among nonsmoking Taiwanese women. Cancer Research. American Association for Cancer Research, 04/01/2001, roč. 61, čís. 7, s. 2799–2803. Dostupné online. PMID 11306446. 

archive.org

ascopubs.org

jco.ascopubs.org

atcs.jp

  • RAMI-PORTA, R, Crowley JJ, Goldstraw P. The revised TNM staging system for lung cancer. Annals of Thoracic and Cardiovascular Surgery. 2009, s. 4–9. Dostupné online. PMID 19262443. 

atsjournals.org

ajrccm.atsjournals.org

  • SLATORE, CG, Au DH, Gould MK. An official American Thoracic Society systematic review: insurance status and disparities in lung cancer practices and outcomes. American Journal of Respiratory and Critical Care Medicine. November 2010, s. 1195–1205. Dostupné online. DOI 10.1164/rccm.2009-038ST. PMID 21041563. 

bbc.co.uk

news.bbc.co.uk

  • PANDEY, G. Bhutan's smokers face public ban. news.bbc.co.uk. BBC, 2005. Dostupné online [cit. 2007-09-07]. 
  • PANDEY, G. Indian ban on smoking in public. news.bbc.co.uk. BBC, 2 October 2008. Dostupné online [cit. 2012-04-25]. 

bmj.com

tobaccocontrol.bmj.com

cancer.gov

seer.cancer.gov

cancer.gov

  • Non-Small Cell Lung Cancer Treatment [online]. National Cancer Institute [cit. 2008-11-22]. Dostupné online. 
  • Small Cell Lung Cancer Treatment [online]. National Cancer Institute, 2012 [cit. 2012-05-16]. Dostupné online. 

cancer.org

  • World Health Organization: Outdoor Air Pollution Causes Cancer. www.cancer.org [online]. [cit. 2015-03-13]. Dostupné v archivu pořízeném z originálu dne 2015-03-04. 

cdc.gov

  • CALIFORNIA ENVIRONMENTAL PROTECTION AGENCY. Health effects of exposure to environmental tobacco smoke. California Environmental Protection Agency. Tobacco Control. 1997, s. 346–353. Dostupné online. DOI 10.1136/tc.6.4.346. PMID 9583639. 
    * Centers for Disease Control and Prevention (CDC). State-specific prevalence of current cigarette smoking among adults, and policies and attitudes about secondhand smoke—United States, 2000. Morbidity and Mortality Weekly Report. Atlanta, Georgia: CDC, 2001, s. 1101–1106. Dostupné online. PMID 11794619. 

chestpubs.org

chestjournal.chestpubs.org

ctsnet.org

  • MOUNTAIN, CF, Libshitz HI, Hermes KE. A Handbook for Staging, Imaging, and Lymph Node Classification. [s.l.]: Charles P Young, 2003. Dostupné online. 

doi.org

dx.doi.org

  • THUN, MJ, Hannan LM, Adams-Campbell LL et al. Lung cancer occurrence in never-smokers: an analysis of 13 cohorts and 22 cancer registry studies. PLoS Medicine. 2008, s. e185. DOI 10.1371/journal.pmed.0050185. PMID 18788891. 
  • FERLAY, J, Shin HR, Bray F et al. Estimates of worldwide burden of cancer in 2008: GLOBOCAN 2008. International Journal of Cancer. December 2010, s. 2893–2917. Dostupné online. DOI 10.1002/ijc.25516. PMID 21351269. 
  • HONNORAT, J, Antoine JC. Paraneoplastic neurological syndromes. Orphanet Journal of Rare Diseases. BioMed Central, 2007, s. 22. Dostupné online. DOI 10.1186/1750-1172-2-22. PMID 17480225. 
  • BIESALSKI, HK, Bueno de Mesquita B, Chesson A et al. European Consensus Statement on Lung Cancer: risk factors and prevention. Lung Cancer Panel. CA Cancer J Clin. Smoking is the major risk factor, accounting for about 90% of lung cancer incidence.: 1998, s. 167–176; discussion 164–166. Dostupné online. DOI 10.3322/canjclin.48.3.167. PMID 9594919. 
  • HECHT, S. Tobacco carcinogens, their biomarkers and tobacco-induced cancer. Nature Reviews. Cancer. Nature Publishing Group, 2003, s. 733–744. Dostupné online. DOI 10.1038/nrc1190. PMID 14570033. 
  • SOPORI, M. Effects of cigarette smoke on the immune system. Nature Reviews. Immunology. 2002, s. 372–7. DOI 10.1038/nri803. PMID 12033743. 
  • CALIFORNIA ENVIRONMENTAL PROTECTION AGENCY. Health effects of exposure to environmental tobacco smoke. California Environmental Protection Agency. Tobacco Control. 1997, s. 346–353. Dostupné online. DOI 10.1136/tc.6.4.346. PMID 9583639. 
    * Centers for Disease Control and Prevention (CDC). State-specific prevalence of current cigarette smoking among adults, and policies and attitudes about secondhand smoke—United States, 2000. Morbidity and Mortality Weekly Report. Atlanta, Georgia: CDC, 2001, s. 1101–1106. Dostupné online. PMID 11794619. 
  • ALBERG, AJ, Samet JM. Epidemiology of lung cancer. Chest. American College of Chest Physicians, 2007, s. 29S–55S. Dostupné v archivu pořízeném dne 2020-03-29. DOI 10.1378/chest.07-1347. PMID 17873159. 
  • JAAKKOLA, MS, Jaakkola JJ. Impact of smoke-free workplace legislation on exposures and health: possibilities for prevention. European Respiratory Journal. 2006, s. 397–408. Dostupné online. DOI 10.1183/09031936.06.00001306. PMID 16880370. 
  • PARKIN, DM. Tobacco—attributable cancer burden in the UK in 2010. British Journal of Cancer. 2011, s. S6–S13. Dostupné online. DOI 10.1038/bjc.2011.475. PMID 22158323. 
  • TAYLOR, R, Najafi F, Dobson A. Meta-analysis of studies of passive smoking and lung cancer: effects of study type and continent. International Journal of Epidemiology. 2007, s. 1048–1059. Dostupné online. DOI 10.1093/ije/dym158. PMID 17690135. 
  • SCHICK, S, Glantz S. Philip Morris toxicological experiments with fresh sidestream smoke: more toxic than mainstream smoke. Tobacco Control. 2005, s. 396–404. DOI 10.1136/tc.2005.011288. PMID 16319363. 
  • Schmid K, Kuwert T, Drexler H. Radon in Indoor Spaces: An Underestimated Risk Factor for Lung Cancer in Environmental Medicine. Dtsch Arztebl Int. 2010, s. 181–6. DOI 10.3238/arztebl.2010.0181. PMID 20386676. 
  • LEROUX, C, Girard N, Cottin V et al. Jaagsiekte Sheep Retrovirus (JSRV): from virus to lung cancer in sheep. Veterinary Research. March-April 2007, roč. 38, čís. 2, s. 211–228. DOI 10.1051/vetres:2006060. PMID 17257570. 
  • PALMARINI, M, Fan H. Retrovirus-induced ovine pulmonary adenocarcinoma, an animal model for lung cancer. Journal of the National Cancer Institute. Oxford University Press, November 2001, roč. 93, čís. 21, s. 1603–1614. Dostupné online. DOI 10.1093/jnci/93.21.1603. PMID 11698564. 
  • ZHENG, H, Aziz HA, Nakanishi Y et al. Oncogenic role of JC virus in lung cancer. Journal of Pathology. May 2007, roč. 212, čís. 3, s. 306–315. Dostupné online. DOI 10.1002/path.2188. PMID 17534844. 
  • GIULIANI, L, Jaxmar T, Casadio C et al. Detection of oncogenic viruses (SV40, BKV, JCV, HCMV, HPV) and p53 codon 72 polymorphism in lung carcinoma. Lung Cancer. September 2007, roč. 57, čís. 3, s. 273–281. DOI 10.1016/j.lungcan.2007.02.019. PMID 17400331. 
  • FONG, KM, Sekido Y, Gazdar AF, Minna JD. Lung cancer • 9: Molecular biology of lung cancer: clinical implications. Thorax. BMJ Publishing Group Ltd., 2003, s. 892–900. DOI 10.1136/thorax.58.10.892. PMID 14514947. 
  • HERBST, RS, Heymach JV, Lippman SM. Lung cancer. New England Journal of Medicine. 2008, s. 1367–1380. Dostupné online. DOI 10.1056/NEJMra0802714. PMID 18815398. 
  • AVIEL-RONEN, S, Blackhall FH, Shepherd FA, Tsao MS. K-ras mutations in non-small-cell lung carcinoma: a review. Clinical Lung Cancer. Cancer Information Group, 2006, s. 30–38. DOI 10.3816/CLC.2006.n.030. PMID 16870043. 
  • DEVEREUX, TR, Taylor JA, Barrett JC. Molecular mechanisms of lung cancer. Interaction of environmental and genetic factors. Chest. American College of Chest Physicians, 1996, s. 14S–19S. DOI 10.1378/chest.109.3_Supplement.14S. PMID 8598134. 
  • ENGELS, EA, Wu X, Gu J et al. Systematic evaluation of genetic variants in the inflammation pathway and risk of lung cancer. Cancer Research. American Association for Cancer Research, July 2007, roč. 67, čís. 13, s. 6520–6527. DOI 10.1158/0008-5472.CAN-07-0370. PMID 17596594. 
  • WENZLAFF, AS, Cote ML, Bock CH et al. CYP1A1 and CYP1B1 polymorphisms and risk of lung cancer among never smokers: a population-based study. Carcinogenesis. Oxford University Press, December 2005, roč. 26, čís. 12, s. 2207–2212. DOI 10.1093/carcin/bgi191. PMID 16051642. 
  • SON, JW, Kang HK, Chae MH et al. Polymorphisms in the caspase-8 gene and the risk of lung cancer. Cancer Genetics and Cytogenetics. September 2006, roč. 169, čís. 2, s. 121–127. DOI 10.1016/j.cancergencyto.2006.04.001. PMID 16938569. 
  • YIN, J, Vogel U, Ma Y et al. The DNA repair gene XRCC1 and genetic susceptibility of lung cancer in a northeastern Chinese population. Lung Cancer. May 2007, roč. 56, čís. 2, s. 153–160. DOI 10.1016/j.lungcan.2006.12.012. PMID 17316890. 
  • Tomoda K, Ohkoshi T, Hirota K, et al.. Preparation and properties of inhalable nanocomposite particles for treatment of lung cancer. Colloids Surf B Biointerfaces. February 2009, roč. 71, s. 177. Dostupné online. DOI 10.1016/j.colsurfb.2009.02.001. PMID 19264458. 
  • SUBRAMANIAN, J, Govindan R. Lung cancer in never smokers: a review. Journal of Clinical Oncology. American Society of Clinical Oncology, 2007, s. 561–570. DOI 10.1200/JCO.2006.06.8015. PMID 17290066. 
  • RAZ, DJ, He B, Rosell R, Jablons DM. Bronchioloalveolar carcinoma: a review. Clinical Lung Cancer. 2006, s. 313–322. DOI 10.3816/CLC.2006.n.012. PMID 16640802. 
  • ROSTI, G, Bevilacqua G, Bidoli P et al. Small cell lung cancer. Annals of Oncology. 2006, s. 5–10. Dostupné online. DOI 10.1093/annonc/mdj910. PMID 16608983. 
  • MCNABOLA, A, Gill LW. The control of environmental tobacco smoke: a policy review. International Journal of Environmental Research and Public Health. 2009, s. 741–758. DOI 10.3390/ijerph6020741. PMID 19440413. 
  • FRITZ, H, Kennedy D, Fergusson D et al. Vitamin A and Retinoid Derivatives for Lung Cancer: A Systematic Review and Meta Analysis. PLoS ONE. 2011, s. e21107. DOI 10.1371/journal.pone.0021107. PMID 21738614. 
  • HERR, C, Greulich T, Koczulla RA et al. The role of vitamin D in pulmonary disease: COPD, asthma, infection, and cancer. Respiratory Research. 2011, s. 31. DOI 10.1186/1465-9921-12-31. PMID 21418564. 
  • KEY, TJ. Fruit and vegetables and cancer risk. British Journal of Cancer. 2011, s. 6–11. DOI 10.1038/sj.bjc.6606032. PMID 21119663. 
  • MANSER, RL, Irving LB, Stone C et al. Screening for lung cancer. Cochrane Database of Systematic Reviews. 2004, s. CD001991. Dostupné online. DOI 10.1002/14651858.CD001991.pub2. PMID 14973979. 
  • JAKLITSCH, MT, Jacobson FL, Austin JH et al. The American Association for Thoracic Surgery guidelines for lung cancer screening using low-dose computed tomography scans for lung cancer survivors and other high-risk groups. Journal of Thoracic and Cardiovascular Surgery. 2012, s. 33–38. DOI 10.1016/j.jtcvs.2012.05.060. PMID 22710039. 
  • BACH, PB, Mirkin JN, Oliver TK et al. Benefits and harms of CT screening for lung cancer: a systematic review. JAMA: the Journal of the American Medical Association. 2012, s. 2418–2429. DOI 10.1001/jama.2012.5521. PMID 22610500. 
  • Bach PB, Mirkin JN, Oliver TK, et al.. Benefits and harms of CT screening for lung cancer: a systematic review. JAMA. 2012, s. 2418–29. DOI 10.1001/jama.2012.5521. PMID 22610500. 
  • FERRELL, B, Koczywas M, Grannis F, Harrington A. Palliative care in lung cancer. Surgical Clinics of North America. 2011, s. 403–417. DOI 10.1016/j.suc.2010.12.003. PMID 21419260. 
  • ODELL, DD, Kent MS, Fernando HC. Sublobar resection with brachytherapy mesh for stage I non-small cell lung cancer. Seminars in Thoracic and Cardiovascular Surgery. 2010, s. 32–37. DOI 10.1053/j.semtcvs.2010.04.003. PMID 20813314. 
  • RUETH, NM, Andrade RS. Is VATS lobectomy better: perioperatively, biologically and oncologically?. Annals of Thoracic Surgery. 2010, s. S2107–S2111. DOI 10.1016/j.athoracsur.2010.03.020. PMID 20493991. 
  • Simon GR, Turrisi A. Management of small cell lung cancer: ACCP evidence-based clinical practice guidelines (2nd edition). Chest. 2007, s. 324S–339S. Dostupné online. DOI 10.1378/chest.07-1385. PMID 17873178. 
  • GOLDSTEIN, SD, Yang SC. Role of surgery in small cell lung cancer. Surgical Oncology Clinics of North America. 2011, s. 769–777. DOI 10.1016/j.soc.2011.08.001. PMID 21986271. 
  • HATTON, MQ, Martin JE. Continuous hyperfractionated accelerated radiotherapy (CHART) and non-conventionally fractionated radiotherapy in the treatment of non-small cell lung cancer: a review and consideration of future directions. Clinical Oncology (Royal College of Radiologists). 2010, s. 356–364. DOI 10.1016/j.clon.2010.03.010. PMID 20399629. 
  • PORT Meta-analysis Trialists Group. Postoperative radiotherapy for non-small cell lung cancer. Redakce Rydzewska Larysa. Cochrane Database of Systematic Reviews. 2005, s. CD002142. Dostupné online. DOI 10.1002/14651858.CD002142.pub2. PMID 15846628.  Archivovaná kopie. mrw.interscience.wiley.com [online]. [cit. 2009-10-14]. Dostupné v archivu pořízeném z originálu dne 2010-02-09. 
  • LE PÉCHOUX, C. Role of postoperative radiotherapy in resected non-small cell lung cancer: a reassessment based on new data. Oncologist. 2011, s. 672–681. DOI 10.1634/theoncologist.2010-0150. PMID 21378080. 
  • CARDONA, AF, Reveiz L, Ospina EG et al. Palliative endobronchial brachytherapy for non-small cell lung cancer. Cochrane Database of Systematic Reviews. 2008, s. CD004284. DOI 10.1002/14651858.CD004284.pub2. PMID 18425900. 
  • PAUMIER, A, Cuenca X, Le Péchoux C. Prophylactic cranial irradiation in lung cancer. Cancer Treatment Reviews. 2011, s. 261–265. DOI 10.1016/j.ctrv.2010.08.009. PMID 20934256. 
  • GIRARD, N, Mornex F. Stereotactic radiotherapy for non-small cell lung cancer: From concept to clinical reality. 2011 update. Cancer Radiothérapie. 2011, s. 522–526. DOI 10.1016/j.canrad.2011.07.241. PMID 21889901. 
  • FAIRCHILD, A, Harris K, Barnes E et al. Palliative thoracic radiotherapy for lung cancer: a systematic review. Journal of Clinical Oncology. 2008, s. 4001–4011. Dostupné online. DOI 10.1200/JCO.2007.15.3312. PMID 18711191. 
  • AZIM, HA, Ganti AK. Treatment options for relapsed small-cell lung cancer. Anticancer drugs. 2007, s. 255–261. DOI 10.1097/CAD.0b013e328011a547. PMID 17264756. 
  • MACCALLUM, C, Gillenwater HH. Second-line treatment of small-cell lung cancer. Current Oncology Reports. 2006, s. 258–264. DOI 10.1007/s11912-006-0030-8. PMID 17254525. 
  • NSCLC Meta-Analyses Collaborative Group. Chemotherapy in Addition to Supportive Care Improves Survival in Advanced Non–Small-Cell Lung Cancer: A Systematic Review and Meta-Analysis of Individual Patient Data From 16 Randomized Controlled Trials. J. Clin. Oncol.. 2008, s. 4617–25. DOI 10.1200/JCO.2008.17.7162. PMID 18678835. 
  • CLEGG, A, Scott DA, Hewitson P et al. Clinical and cost effectiveness of paclitaxel, docetaxel, gemcitabine, and vinorelbine in non-small cell lung cancer: a systematic review. Thorax. BMJ Publishing Group, 2002, s. 20–28. DOI 10.1136/thorax.57.1.20. PMID 11809985. 
  • Fuld AD, Dragnev KH, Rigas JR. Pemetrexed in advanced non-small-cell lung cancer. Expert Opin Pharmacother. 2010, s. 1387–402. DOI 10.1517/14656566.2010.482560. PMID 20446853. 
  • CARBONE, DP, Felip E. Adjuvant therapy in non-small cell lung cancer: future treatment prospects and paradigms. Clinical Lung Cancer. 2011, s. 261–271. DOI 10.1016/j.cllc.2011.06.002. PMID 21831720. 
  • LE CHEVALIER, T. Adjuvant chemotherapy for resectable non-small-cell lung cancer: where is it going?. Annals of Oncology. 2010, s. vii196–198. Dostupné online. DOI 10.1093/annonc/mdq376. PMID 20943614. 
  • HORN, L, Sandler AB, Putnam JB Jr, Johnson DH. The rationale for adjuvant chemotherapy in stage I non-small cell lung cancer. Journal of Thoracic Oncology. 2007, s. 377–383. DOI 10.1097/01.JTO.0000268669.64625.bb. PMID 17473651. 
  • WAKELEE, HA, Schiller JH, Gandara DR. Current status of adjuvant chemotherapy for stage IB non-small-cell lung cancer: implications for the New Intergroup Trial. Clinical Lung Cancer. Cancer Information Group, 2006, s. 18–21. DOI 10.3816/CLC.2006.n.028. PMID 16870041. 
  • Kelley AS, Meier DE. Palliative care—a shifting paradigm. New England Journal of Medicine. 2010, s. 781–2. DOI 10.1056/NEJMe1004139. PMID 20818881. 
  • Souquet PJ, Chauvin F, Boissel JP, Bernard JP. Meta-analysis of randomised trials of systemic chemotherapy versus supportive treatment in non-resectable non-small cell lung cancer. Lung Cancer. 1995, s. S147–54. DOI 10.1016/0169-5002(95)00430-9. PMID 7551923. 
  • SLATORE, CG, Au DH, Gould MK. An official American Thoracic Society systematic review: insurance status and disparities in lung cancer practices and outcomes. American Journal of Respiratory and Critical Care Medicine. November 2010, s. 1195–1205. Dostupné online. DOI 10.1164/rccm.2009-038ST. PMID 21041563. 
  • Jemal A, Tiwari RC, Murray T, et al.. Cancer statistics, 2004. CA: a Cancer Journal for Clinicians. 2004, s. 8–29. DOI 10.3322/canjclin.54.1.8. PMID 14974761. 
  • PROCTOR, RN. The history of the discovery of the cigarette-lung cancer link: evidentiary traditions, corporate denial, global toll. Tobacco Control. 2012, s. 87–91. DOI 10.1136/tobaccocontrol-2011-050338. PMID 22345227. 
  • LUM, KL, Polansky JR, Jackler RK, Glantz SA. Signed, sealed and delivered: "big tobacco" in Hollywood, 1927–1951. Tobacco Control. 2008, s. 313–323. Dostupné online. DOI 10.1136/tc.2008.025445. PMID 18818225. 
  • LOVATO, C, Watts A, Stead LF. Impact of tobacco advertising and promotion on increasing adolescent smoking behaviours. Cochrane Database of Systematic Reviews. October 2011, s. CD003439. DOI 10.1002/14651858.CD003439.pub2. PMID 21975739. 
  • ZHANG, J, Ou JX, Bai CX. Tobacco smoking in China: prevalence, disease burden, challenges and future strategies. Respirology. November 2011, s. 1165–1172. DOI 10.1111/j.1440-1843.2011.02062.x. PMID 21910781. 
  • CHARLOUX, A, Quoix E, Wolkove N et al. The increasing incidence of lung adenocarcinoma: reality or artefact? A review of the epidemiology of lung adenocarcinoma. International Journal of Epidemiology. 1997, s. 14–23. Dostupné online. DOI 10.1093/ije/26.1.14. PMID 9126499. 
  • KADARA, H, Kabbout M, Wistuba II. Pulmonary adenocarcinoma: a renewed entity in 2011. Respirology. 2012, s. 50–65. DOI 10.1111/j.1440-1843.2011.02095.x. PMID 22040022. 
  • WITSCHI, H. A short history of lung cancer. Toxicological Sciences. 2001, s. 4–6. Dostupné online. DOI 10.1093/toxsci/64.1.4. PMID 11606795. 
  • Adler, I. Primary Malignant Growths of the Lungs and Bronchi. New York: Longmans, Green, and Company, 1912. OCLC 14783544 , cited in Spiro SG, Silvestri GA. One hundred years of lung cancer. American Journal of Respiratory and Critical Care Medicine. 2005, s. 523–529. DOI 10.1164/rccm.200504-531OE. PMID 15961694. 
  • DOLL, R, Hill AB. Lung Cancer and Other Causes of Death in Relation to Smoking. British Medical Journal. 1956, s. 1071–1081. DOI 10.1136/bmj.2.5001.1071. PMID 13364389. 
  • SAMET, JM. Radiation and cancer risk: a continuing challenge for epidemiologists. Environmental Health. 2011, s. S4. DOI 10.1186/1476-069X-10-S1-S4. PMID 21489214. 
  • HORN, L, Johnson DH. Evarts A. Graham and the first pneumonectomy for lung cancer. Journal of Clinical Oncology. 2008, s. 3268–3275. Dostupné online. DOI 10.1200/JCO.2008.16.8260. PMID 18591561. 
  • EDWARDS, AT. Carcinoma of the Bronchus. Thorax. 1946, s. 1–25. DOI 10.1136/thx.1.1.1. PMID 20986395. 
  • SAUNDERS, M, Dische S, Barrett A et al. Continuous hyperfractionated accelerated radiotherapy (CHART) versus conventional radiotherapy in non-small-cell lung cancer: a randomised multicentre trial. Lancet. Elsevier, 1997, s. 161–165. DOI 10.1016/S0140-6736(97)06305-8. PMID 9250182. 
  • LENNOX, SC, Flavell G, Pollock DJ et al. Results of resection for oat-cell carcinoma of the lung. Lancet. Elsevier, 1968, s. 925–927. DOI 10.1016/S0140-6736(68)91163-X. PMID 4176258. 
  • MILLER, AB, Fox W, Tall R. Five-year follow-up of the Medical Research Council comparative trial of surgery and radiotherapy for the primary treatment of small-celled or oat-celled carcinoma of the bronchus. Lancet. Elsevier, 1969, s. 501–505. DOI 10.1016/S0140-6736(69)90212-8. PMID 4184834. 

druglibrary.org

  • CALIFORNIA ENVIRONMENTAL PROTECTION AGENCY. Health effects of exposure to environmental tobacco smoke. California Environmental Protection Agency. Tobacco Control. 1997, s. 346–353. Dostupné online. DOI 10.1136/tc.6.4.346. PMID 9583639. 
    * Centers for Disease Control and Prevention (CDC). State-specific prevalence of current cigarette smoking among adults, and policies and attitudes about secondhand smoke—United States, 2000. Morbidity and Mortality Weekly Report. Atlanta, Georgia: CDC, 2001, s. 1101–1106. Dostupné online. PMID 11794619. 

elsevier.com

linkinghub.elsevier.com

epa.gov

  • EPA. Radiation information: radon [online]. EPA, 2006 [cit. 2007-08-11]. Dostupné online. 

ersjournals.com

erj.ersjournals.com

google.ca

books.google.ca

  • DUDLEY, Joel. Exploring Personal Genomics. [s.l.]: Oxford University Press, 2013. Dostupné online. ISBN 9780199644483. S. 25. 

iarc.fr

monographs.iarc.fr

  • Tobacco Smoke and Involuntary Smoking. IARC Monographs on the Evaluation of Carcinogenic Risks to Humans. WHO International Agency for Research on Cancer, 2002. Dostupné online. 
  • COGLIANO, VJ, Baan, R; Straif, K; Grosse, Y; Lauby-Secretan, B; El Ghissassi, F; Bouvard, V; Benbrahim-Tallaa, L; Guha, N; Freeman, C; Galichet, L; Wild, CP. Preventable exposures associated with human cancers.. Journal of the National Cancer Institute. 2011 Dec 21, s. 1827-39. Dostupné v archivu pořízeném dne 2012-09-20. PMID 22158127.  Archivovaná kopie. monographs.iarc.fr [online]. [cit. 2014-07-31]. Dostupné v archivu pořízeném z originálu dne 2012-09-20. 

jst.go.jp

jstage.jst.go.jp

merck.com

  • Lung Carcinoma: Tumors of the Lungs [online]. Merck Manual Professional Edition, Online edition [cit. 2007-08-15]. Dostupné online. 

nature.com

  • HECHT, S. Tobacco carcinogens, their biomarkers and tobacco-induced cancer. Nature Reviews. Cancer. Nature Publishing Group, 2003, s. 733–744. Dostupné online. DOI 10.1038/nrc1190. PMID 14570033. 

nejm.org

content.nejm.org

nih.gov

ncbi.nlm.nih.gov

  • THUN, MJ, Hannan LM, Adams-Campbell LL et al. Lung cancer occurrence in never-smokers: an analysis of 13 cohorts and 22 cancer registry studies. PLoS Medicine. 2008, s. e185. DOI 10.1371/journal.pmed.0050185. PMID 18788891. 
  • O'REILLY, KM, Mclaughlin AM, Beckett WS, Sime PJ. Asbestos-related lung disease. American Family Physician. 2007, s. 683–688. Dostupné v archivu pořízeném dne 2007-09-29. PMID 17375514. 
  • COLLINS, LG, Haines C, Perkel R, Enck RE. Lung cancer: diagnosis and management. American Family Physician. American Academy of Family Physicians, January 2007, roč. 75, čís. 1, s. 56–63. Dostupné v archivu pořízeném dne 2007-09-29. PMID 17225705.  Archivováno 29. 9. 2007 na Wayback Machine.
  • FERLAY, J, Shin HR, Bray F et al. Estimates of worldwide burden of cancer in 2008: GLOBOCAN 2008. International Journal of Cancer. December 2010, s. 2893–2917. Dostupné online. DOI 10.1002/ijc.25516. PMID 21351269. 
  • HONNORAT, J, Antoine JC. Paraneoplastic neurological syndromes. Orphanet Journal of Rare Diseases. BioMed Central, 2007, s. 22. Dostupné online. DOI 10.1186/1750-1172-2-22. PMID 17480225. 
  • BIESALSKI, HK, Bueno de Mesquita B, Chesson A et al. European Consensus Statement on Lung Cancer: risk factors and prevention. Lung Cancer Panel. CA Cancer J Clin. Smoking is the major risk factor, accounting for about 90% of lung cancer incidence.: 1998, s. 167–176; discussion 164–166. Dostupné online. DOI 10.3322/canjclin.48.3.167. PMID 9594919. 
  • HECHT, S. Tobacco carcinogens, their biomarkers and tobacco-induced cancer. Nature Reviews. Cancer. Nature Publishing Group, 2003, s. 733–744. Dostupné online. DOI 10.1038/nrc1190. PMID 14570033. 
  • SOPORI, M. Effects of cigarette smoke on the immune system. Nature Reviews. Immunology. 2002, s. 372–7. DOI 10.1038/nri803. PMID 12033743. 
  • CALIFORNIA ENVIRONMENTAL PROTECTION AGENCY. Health effects of exposure to environmental tobacco smoke. California Environmental Protection Agency. Tobacco Control. 1997, s. 346–353. Dostupné online. DOI 10.1136/tc.6.4.346. PMID 9583639. 
    * Centers for Disease Control and Prevention (CDC). State-specific prevalence of current cigarette smoking among adults, and policies and attitudes about secondhand smoke—United States, 2000. Morbidity and Mortality Weekly Report. Atlanta, Georgia: CDC, 2001, s. 1101–1106. Dostupné online. PMID 11794619. 
  • ALBERG, AJ, Samet JM. Epidemiology of lung cancer. Chest. American College of Chest Physicians, 2007, s. 29S–55S. Dostupné v archivu pořízeném dne 2020-03-29. DOI 10.1378/chest.07-1347. PMID 17873159. 
  • JAAKKOLA, MS, Jaakkola JJ. Impact of smoke-free workplace legislation on exposures and health: possibilities for prevention. European Respiratory Journal. 2006, s. 397–408. Dostupné online. DOI 10.1183/09031936.06.00001306. PMID 16880370. 
  • PARKIN, DM. Tobacco—attributable cancer burden in the UK in 2010. British Journal of Cancer. 2011, s. S6–S13. Dostupné online. DOI 10.1038/bjc.2011.475. PMID 22158323. 
  • TAYLOR, R, Najafi F, Dobson A. Meta-analysis of studies of passive smoking and lung cancer: effects of study type and continent. International Journal of Epidemiology. 2007, s. 1048–1059. Dostupné online. DOI 10.1093/ije/dym158. PMID 17690135. 
  • SCHICK, S, Glantz S. Philip Morris toxicological experiments with fresh sidestream smoke: more toxic than mainstream smoke. Tobacco Control. 2005, s. 396–404. DOI 10.1136/tc.2005.011288. PMID 16319363. 
  • Schmid K, Kuwert T, Drexler H. Radon in Indoor Spaces: An Underestimated Risk Factor for Lung Cancer in Environmental Medicine. Dtsch Arztebl Int. 2010, s. 181–6. DOI 10.3238/arztebl.2010.0181. PMID 20386676. 
  • CHEN, H, Goldberg MS, Villeneuve PJ. A systematic review of the relation between long-term exposure to ambient air pollution and chronic diseases. Reviews on Environmental Health. 2008, s. 243–297. PMID 19235364. 
  • CLAPP, RW, Jacobs MM, Loechler EL. Environmental and Occupational Causes of Cancer New Evidence, 2005–2007. Reviews on Environmental Health. 2008, s. 1–37. Dostupné online. PMID 18557596. 
  • LIM, WY, Seow, A. Biomass fuels and lung cancer.. Respirology (Carlton, Vic.). 2012 Jan, s. 20-31. PMID 22008241. 
  • SOOD, A. Indoor fuel exposure and the lung in both developing and developed countries: an update.. Clinics in chest medicine. 2012 Dec, s. 649-65. PMID 23153607. 
  • LEROUX, C, Girard N, Cottin V et al. Jaagsiekte Sheep Retrovirus (JSRV): from virus to lung cancer in sheep. Veterinary Research. March-April 2007, roč. 38, čís. 2, s. 211–228. DOI 10.1051/vetres:2006060. PMID 17257570. 
  • PALMARINI, M, Fan H. Retrovirus-induced ovine pulmonary adenocarcinoma, an animal model for lung cancer. Journal of the National Cancer Institute. Oxford University Press, November 2001, roč. 93, čís. 21, s. 1603–1614. Dostupné online. DOI 10.1093/jnci/93.21.1603. PMID 11698564. 
  • CHENG, YW, Chiou HL, Sheu GT et al. The association of human papillomavirus 16/18 infection with lung cancer among nonsmoking Taiwanese women. Cancer Research. American Association for Cancer Research, 04/01/2001, roč. 61, čís. 7, s. 2799–2803. Dostupné online. PMID 11306446. 
  • ZHENG, H, Aziz HA, Nakanishi Y et al. Oncogenic role of JC virus in lung cancer. Journal of Pathology. May 2007, roč. 212, čís. 3, s. 306–315. Dostupné online. DOI 10.1002/path.2188. PMID 17534844. 
  • GIULIANI, L, Jaxmar T, Casadio C et al. Detection of oncogenic viruses (SV40, BKV, JCV, HCMV, HPV) and p53 codon 72 polymorphism in lung carcinoma. Lung Cancer. September 2007, roč. 57, čís. 3, s. 273–281. DOI 10.1016/j.lungcan.2007.02.019. PMID 17400331. 
  • COGLIANO, VJ, Baan, R; Straif, K; Grosse, Y; Lauby-Secretan, B; El Ghissassi, F; Bouvard, V; Benbrahim-Tallaa, L; Guha, N; Freeman, C; Galichet, L; Wild, CP. Preventable exposures associated with human cancers.. Journal of the National Cancer Institute. 2011 Dec 21, s. 1827-39. Dostupné v archivu pořízeném dne 2012-09-20. PMID 22158127.  Archivovaná kopie. monographs.iarc.fr [online]. [cit. 2014-07-31]. Dostupné v archivu pořízeném z originálu dne 2012-09-20. 
  • FONG, KM, Sekido Y, Gazdar AF, Minna JD. Lung cancer • 9: Molecular biology of lung cancer: clinical implications. Thorax. BMJ Publishing Group Ltd., 2003, s. 892–900. DOI 10.1136/thorax.58.10.892. PMID 14514947. 
  • SALGIA, R, Skarin AT. Molecular abnormalities in lung cancer. Journal of Clinical Oncology. 1998, s. 1207–1217. PMID 9508209. 
  • HERBST, RS, Heymach JV, Lippman SM. Lung cancer. New England Journal of Medicine. 2008, s. 1367–1380. Dostupné online. DOI 10.1056/NEJMra0802714. PMID 18815398. 
  • AVIEL-RONEN, S, Blackhall FH, Shepherd FA, Tsao MS. K-ras mutations in non-small-cell lung carcinoma: a review. Clinical Lung Cancer. Cancer Information Group, 2006, s. 30–38. DOI 10.3816/CLC.2006.n.030. PMID 16870043. 
  • DEVEREUX, TR, Taylor JA, Barrett JC. Molecular mechanisms of lung cancer. Interaction of environmental and genetic factors. Chest. American College of Chest Physicians, 1996, s. 14S–19S. DOI 10.1378/chest.109.3_Supplement.14S. PMID 8598134. 
  • ENGELS, EA, Wu X, Gu J et al. Systematic evaluation of genetic variants in the inflammation pathway and risk of lung cancer. Cancer Research. American Association for Cancer Research, July 2007, roč. 67, čís. 13, s. 6520–6527. DOI 10.1158/0008-5472.CAN-07-0370. PMID 17596594. 
  • WENZLAFF, AS, Cote ML, Bock CH et al. CYP1A1 and CYP1B1 polymorphisms and risk of lung cancer among never smokers: a population-based study. Carcinogenesis. Oxford University Press, December 2005, roč. 26, čís. 12, s. 2207–2212. DOI 10.1093/carcin/bgi191. PMID 16051642. 
  • SON, JW, Kang HK, Chae MH et al. Polymorphisms in the caspase-8 gene and the risk of lung cancer. Cancer Genetics and Cytogenetics. September 2006, roč. 169, čís. 2, s. 121–127. DOI 10.1016/j.cancergencyto.2006.04.001. PMID 16938569. 
  • YIN, J, Vogel U, Ma Y et al. The DNA repair gene XRCC1 and genetic susceptibility of lung cancer in a northeastern Chinese population. Lung Cancer. May 2007, roč. 56, čís. 2, s. 153–160. DOI 10.1016/j.lungcan.2006.12.012. PMID 17316890. 
  • Tomoda K, Ohkoshi T, Hirota K, et al.. Preparation and properties of inhalable nanocomposite particles for treatment of lung cancer. Colloids Surf B Biointerfaces. February 2009, roč. 71, s. 177. Dostupné online. DOI 10.1016/j.colsurfb.2009.02.001. PMID 19264458. 
  • SUBRAMANIAN, J, Govindan R. Lung cancer in never smokers: a review. Journal of Clinical Oncology. American Society of Clinical Oncology, 2007, s. 561–570. DOI 10.1200/JCO.2006.06.8015. PMID 17290066. 
  • RAZ, DJ, He B, Rosell R, Jablons DM. Bronchioloalveolar carcinoma: a review. Clinical Lung Cancer. 2006, s. 313–322. DOI 10.3816/CLC.2006.n.012. PMID 16640802. 
  • ROSTI, G, Bevilacqua G, Bidoli P et al. Small cell lung cancer. Annals of Oncology. 2006, s. 5–10. Dostupné online. DOI 10.1093/annonc/mdj910. PMID 16608983. 
  • SEO, JB, Im JG, Goo JM et al. Atypical pulmonary metastases: spectrum of radiologic findings. Radiographics. 1 March 2001, s. 403–417. Dostupné online. PMID 11259704. 
  • Tan D, Zander DS. Immunohistochemistry for Assessment of Pulmonary and Pleural Neoplasms: A Review and Update. Int J Clin Exp Pathol. 2008, s. 19–31. PMID 18784820. 
  • RAMI-PORTA, R, Crowley JJ, Goldstraw P. The revised TNM staging system for lung cancer. Annals of Thoracic and Cardiovascular Surgery. 2009, s. 4–9. Dostupné online. PMID 19262443. 
  • GOODMAN, GE. Lung cancer. 1: prevention of lung cancer. Thorax. 2002, s. 994–999. Dostupné online. PMID 12403886. 
  • MCNABOLA, A, Gill LW. The control of environmental tobacco smoke: a policy review. International Journal of Environmental Research and Public Health. 2009, s. 741–758. DOI 10.3390/ijerph6020741. PMID 19440413. 
  • FABRICIUS, P, Lange P. Diet and lung cancer. Monaldi Archives for Chest Disease. 2003, s. 207–211. PMID 15065316. 
  • FRITZ, H, Kennedy D, Fergusson D et al. Vitamin A and Retinoid Derivatives for Lung Cancer: A Systematic Review and Meta Analysis. PLoS ONE. 2011, s. e21107. DOI 10.1371/journal.pone.0021107. PMID 21738614. 
  • HERR, C, Greulich T, Koczulla RA et al. The role of vitamin D in pulmonary disease: COPD, asthma, infection, and cancer. Respiratory Research. 2011, s. 31. DOI 10.1186/1465-9921-12-31. PMID 21418564. 
  • KEY, TJ. Fruit and vegetables and cancer risk. British Journal of Cancer. 2011, s. 6–11. DOI 10.1038/sj.bjc.6606032. PMID 21119663. 
  • MANSER, RL, Irving LB, Stone C et al. Screening for lung cancer. Cochrane Database of Systematic Reviews. 2004, s. CD001991. Dostupné online. DOI 10.1002/14651858.CD001991.pub2. PMID 14973979. 
  • JAKLITSCH, MT, Jacobson FL, Austin JH et al. The American Association for Thoracic Surgery guidelines for lung cancer screening using low-dose computed tomography scans for lung cancer survivors and other high-risk groups. Journal of Thoracic and Cardiovascular Surgery. 2012, s. 33–38. DOI 10.1016/j.jtcvs.2012.05.060. PMID 22710039. 
  • BACH, PB, Mirkin JN, Oliver TK et al. Benefits and harms of CT screening for lung cancer: a systematic review. JAMA: the Journal of the American Medical Association. 2012, s. 2418–2429. DOI 10.1001/jama.2012.5521. PMID 22610500. 
  • BOISELLE, PM. Computed tomography screening for lung cancer.. JAMA : the journal of the American Medical Association. 2013 Mar 20, s. 1163-70. PMID 23512063. 
  • Bach PB, Mirkin JN, Oliver TK, et al.. Benefits and harms of CT screening for lung cancer: a systematic review. JAMA. 2012, s. 2418–29. DOI 10.1001/jama.2012.5521. PMID 22610500. 
  • ABERLE, DR, Abtin, F; Brown, K. Computed tomography screening for lung cancer: has it finally arrived? Implications of the national lung screening trial.. Journal of clinical oncology : official journal of the American Society of Clinical Oncology. 2013 Mar 10, s. 1002-8. PMID 23401434. 
  • FERRELL, B, Koczywas M, Grannis F, Harrington A. Palliative care in lung cancer. Surgical Clinics of North America. 2011, s. 403–417. DOI 10.1016/j.suc.2010.12.003. PMID 21419260. 
  • ODELL, DD, Kent MS, Fernando HC. Sublobar resection with brachytherapy mesh for stage I non-small cell lung cancer. Seminars in Thoracic and Cardiovascular Surgery. 2010, s. 32–37. DOI 10.1053/j.semtcvs.2010.04.003. PMID 20813314. 
  • ALAM, N, Flores RM. Video-assisted thoracic surgery (VATS) lobectomy: the evidence base. Journal of the Society of Laparoendoscopic Surgeons. 2007, s. 368–374. PMID 17931521. 
  • RUETH, NM, Andrade RS. Is VATS lobectomy better: perioperatively, biologically and oncologically?. Annals of Thoracic Surgery. 2010, s. S2107–S2111. DOI 10.1016/j.athoracsur.2010.03.020. PMID 20493991. 
  • Simon GR, Turrisi A. Management of small cell lung cancer: ACCP evidence-based clinical practice guidelines (2nd edition). Chest. 2007, s. 324S–339S. Dostupné online. DOI 10.1378/chest.07-1385. PMID 17873178. 
  • GOLDSTEIN, SD, Yang SC. Role of surgery in small cell lung cancer. Surgical Oncology Clinics of North America. 2011, s. 769–777. DOI 10.1016/j.soc.2011.08.001. PMID 21986271. 
  • HATTON, MQ, Martin JE. Continuous hyperfractionated accelerated radiotherapy (CHART) and non-conventionally fractionated radiotherapy in the treatment of non-small cell lung cancer: a review and consideration of future directions. Clinical Oncology (Royal College of Radiologists). 2010, s. 356–364. DOI 10.1016/j.clon.2010.03.010. PMID 20399629. 
  • PORT Meta-analysis Trialists Group. Postoperative radiotherapy for non-small cell lung cancer. Redakce Rydzewska Larysa. Cochrane Database of Systematic Reviews. 2005, s. CD002142. Dostupné online. DOI 10.1002/14651858.CD002142.pub2. PMID 15846628.  Archivovaná kopie. mrw.interscience.wiley.com [online]. [cit. 2009-10-14]. Dostupné v archivu pořízeném z originálu dne 2010-02-09. 
  • LE PÉCHOUX, C. Role of postoperative radiotherapy in resected non-small cell lung cancer: a reassessment based on new data. Oncologist. 2011, s. 672–681. DOI 10.1634/theoncologist.2010-0150. PMID 21378080. 
  • CARDONA, AF, Reveiz L, Ospina EG et al. Palliative endobronchial brachytherapy for non-small cell lung cancer. Cochrane Database of Systematic Reviews. 2008, s. CD004284. DOI 10.1002/14651858.CD004284.pub2. PMID 18425900. 
  • IKUSHIMA, H. Radiation therapy: state of the art and the future. Journal of Medical Investigation. 2010, s. 1–11. Dostupné online. PMID 20299738. [nedostupný zdroj]
  • PAUMIER, A, Cuenca X, Le Péchoux C. Prophylactic cranial irradiation in lung cancer. Cancer Treatment Reviews. 2011, s. 261–265. DOI 10.1016/j.ctrv.2010.08.009. PMID 20934256. 
  • GIRARD, N, Mornex F. Stereotactic radiotherapy for non-small cell lung cancer: From concept to clinical reality. 2011 update. Cancer Radiothérapie. 2011, s. 522–526. DOI 10.1016/j.canrad.2011.07.241. PMID 21889901. 
  • FAIRCHILD, A, Harris K, Barnes E et al. Palliative thoracic radiotherapy for lung cancer: a systematic review. Journal of Clinical Oncology. 2008, s. 4001–4011. Dostupné online. DOI 10.1200/JCO.2007.15.3312. PMID 18711191. 
  • Hann CL, Rudin CM. Management of small-cell lung cancer: incremental changes but hope for the future. Oncology (Williston Park). 2008-11-30, s. 1486–92. PMID 19133604. 
  • MURRAY, N, Turrisi AT. A review of first-line treatment for small-cell lung cancer. Journal of Thoracic Oncology. 2006, s. 270–278. PMID 17409868. 
  • AZIM, HA, Ganti AK. Treatment options for relapsed small-cell lung cancer. Anticancer drugs. 2007, s. 255–261. DOI 10.1097/CAD.0b013e328011a547. PMID 17264756. 
  • MACCALLUM, C, Gillenwater HH. Second-line treatment of small-cell lung cancer. Current Oncology Reports. 2006, s. 258–264. DOI 10.1007/s11912-006-0030-8. PMID 17254525. 
  • NSCLC Meta-Analyses Collaborative Group. Chemotherapy in Addition to Supportive Care Improves Survival in Advanced Non–Small-Cell Lung Cancer: A Systematic Review and Meta-Analysis of Individual Patient Data From 16 Randomized Controlled Trials. J. Clin. Oncol.. 2008, s. 4617–25. DOI 10.1200/JCO.2008.17.7162. PMID 18678835. 
  • CLEGG, A, Scott DA, Hewitson P et al. Clinical and cost effectiveness of paclitaxel, docetaxel, gemcitabine, and vinorelbine in non-small cell lung cancer: a systematic review. Thorax. BMJ Publishing Group, 2002, s. 20–28. DOI 10.1136/thorax.57.1.20. PMID 11809985. 
  • Fuld AD, Dragnev KH, Rigas JR. Pemetrexed in advanced non-small-cell lung cancer. Expert Opin Pharmacother. 2010, s. 1387–402. DOI 10.1517/14656566.2010.482560. PMID 20446853. 
  • CARBONE, DP, Felip E. Adjuvant therapy in non-small cell lung cancer: future treatment prospects and paradigms. Clinical Lung Cancer. 2011, s. 261–271. DOI 10.1016/j.cllc.2011.06.002. PMID 21831720. 
  • LE CHEVALIER, T. Adjuvant chemotherapy for resectable non-small-cell lung cancer: where is it going?. Annals of Oncology. 2010, s. vii196–198. Dostupné online. DOI 10.1093/annonc/mdq376. PMID 20943614. 
  • HORN, L, Sandler AB, Putnam JB Jr, Johnson DH. The rationale for adjuvant chemotherapy in stage I non-small cell lung cancer. Journal of Thoracic Oncology. 2007, s. 377–383. DOI 10.1097/01.JTO.0000268669.64625.bb. PMID 17473651. 
  • WAKELEE, HA, Schiller JH, Gandara DR. Current status of adjuvant chemotherapy for stage IB non-small-cell lung cancer: implications for the New Intergroup Trial. Clinical Lung Cancer. Cancer Information Group, 2006, s. 18–21. DOI 10.3816/CLC.2006.n.028. PMID 16870041. 
  • Kelley AS, Meier DE. Palliative care—a shifting paradigm. New England Journal of Medicine. 2010, s. 781–2. DOI 10.1056/NEJMe1004139. PMID 20818881. 
  • Prince-Paul M. When hospice is the best option: an opportunity to redefine goals. Oncology (Williston Park, N.Y.). 2009, s. 13–7. PMID 19856592. 
  • Souquet PJ, Chauvin F, Boissel JP, Bernard JP. Meta-analysis of randomised trials of systemic chemotherapy versus supportive treatment in non-resectable non-small cell lung cancer. Lung Cancer. 1995, s. S147–54. DOI 10.1016/0169-5002(95)00430-9. PMID 7551923. 
  • Sörenson S, Glimelius B, Nygren P. A systematic overview of chemotherapy effects in non-small cell lung cancer. Acta Oncol. 2001, s. 327–39. PMID 11441939. 
  • Clegg A, Scott DA, Sidhu M, Hewitson P, Waugh N. A rapid and systematic review of the clinical effectiveness and cost-effectiveness of paclitaxel, docetaxel, gemcitabine and vinorelbine in non-small-cell lung cancer. Health Technol Assess. 2001, s. 1–195. PMID 12065068. 
  • SLATORE, CG, Au DH, Gould MK. An official American Thoracic Society systematic review: insurance status and disparities in lung cancer practices and outcomes. American Journal of Respiratory and Critical Care Medicine. November 2010, s. 1195–1205. Dostupné online. DOI 10.1164/rccm.2009-038ST. PMID 21041563. 
  • Jemal A, Tiwari RC, Murray T, et al.. Cancer statistics, 2004. CA: a Cancer Journal for Clinicians. 2004, s. 8–29. DOI 10.3322/canjclin.54.1.8. PMID 14974761. 
  • PROCTOR, RN. The history of the discovery of the cigarette-lung cancer link: evidentiary traditions, corporate denial, global toll. Tobacco Control. 2012, s. 87–91. DOI 10.1136/tobaccocontrol-2011-050338. PMID 22345227. 
  • LUM, KL, Polansky JR, Jackler RK, Glantz SA. Signed, sealed and delivered: "big tobacco" in Hollywood, 1927–1951. Tobacco Control. 2008, s. 313–323. Dostupné online. DOI 10.1136/tc.2008.025445. PMID 18818225. 
  • LOVATO, C, Watts A, Stead LF. Impact of tobacco advertising and promotion on increasing adolescent smoking behaviours. Cochrane Database of Systematic Reviews. October 2011, s. CD003439. DOI 10.1002/14651858.CD003439.pub2. PMID 21975739. 
  • KEMP, FB. Smoke free policies in Europe. An overview. Pneumologia. 2009, s. 155–158. PMID 19817310. 
  • ZHANG, J, Ou JX, Bai CX. Tobacco smoking in China: prevalence, disease burden, challenges and future strategies. Respirology. November 2011, s. 1165–1172. DOI 10.1111/j.1440-1843.2011.02062.x. PMID 21910781. 
  • BEHERA, D, Balamugesh T. Lung cancer in India. Indian Journal of Chest Diseases and Allied Sciences. 2004, s. 269–281. Dostupné online. PMID 15515828. 
  • CHARLOUX, A, Quoix E, Wolkove N et al. The increasing incidence of lung adenocarcinoma: reality or artefact? A review of the epidemiology of lung adenocarcinoma. International Journal of Epidemiology. 1997, s. 14–23. Dostupné online. DOI 10.1093/ije/26.1.14. PMID 9126499. 
  • KADARA, H, Kabbout M, Wistuba II. Pulmonary adenocarcinoma: a renewed entity in 2011. Respirology. 2012, s. 50–65. DOI 10.1111/j.1440-1843.2011.02095.x. PMID 22040022. 
  • WITSCHI, H. A short history of lung cancer. Toxicological Sciences. 2001, s. 4–6. Dostupné online. DOI 10.1093/toxsci/64.1.4. PMID 11606795. 
  • Adler, I. Primary Malignant Growths of the Lungs and Bronchi. New York: Longmans, Green, and Company, 1912. OCLC 14783544 , cited in Spiro SG, Silvestri GA. One hundred years of lung cancer. American Journal of Respiratory and Critical Care Medicine. 2005, s. 523–529. DOI 10.1164/rccm.200504-531OE. PMID 15961694. 
  • DOLL, R, Hill AB. Lung Cancer and Other Causes of Death in Relation to Smoking. British Medical Journal. 1956, s. 1071–1081. DOI 10.1136/bmj.2.5001.1071. PMID 13364389. 
  • GREENBERG, M, Selikoff IJ. Lung cancer in the Schneeberg mines: a reappraisal of the data reported by Harting and Hesse in 1879. Annals of Occupational Hygiene. 1993, s. 5–14. PMID 8460878. 
  • SAMET, JM. Radiation and cancer risk: a continuing challenge for epidemiologists. Environmental Health. 2011, s. S4. DOI 10.1186/1476-069X-10-S1-S4. PMID 21489214. 
  • HORN, L, Johnson DH. Evarts A. Graham and the first pneumonectomy for lung cancer. Journal of Clinical Oncology. 2008, s. 3268–3275. Dostupné online. DOI 10.1200/JCO.2008.16.8260. PMID 18591561. 
  • EDWARDS, AT. Carcinoma of the Bronchus. Thorax. 1946, s. 1–25. DOI 10.1136/thx.1.1.1. PMID 20986395. 
  • KABELA, M. Erfahrungen mit der radikalen Röntgenbestrahlung des Bronchienkrebses. Ceskoslovenská Onkológia. 1956, s. 109–115. PMID 13383622. (German) 
  • SAUNDERS, M, Dische S, Barrett A et al. Continuous hyperfractionated accelerated radiotherapy (CHART) versus conventional radiotherapy in non-small-cell lung cancer: a randomised multicentre trial. Lancet. Elsevier, 1997, s. 161–165. DOI 10.1016/S0140-6736(97)06305-8. PMID 9250182. 
  • LENNOX, SC, Flavell G, Pollock DJ et al. Results of resection for oat-cell carcinoma of the lung. Lancet. Elsevier, 1968, s. 925–927. DOI 10.1016/S0140-6736(68)91163-X. PMID 4176258. 
  • MILLER, AB, Fox W, Tall R. Five-year follow-up of the Medical Research Council comparative trial of surgery and radiotherapy for the primary treatment of small-celled or oat-celled carcinoma of the bronchus. Lancet. Elsevier, 1969, s. 501–505. DOI 10.1016/S0140-6736(69)90212-8. PMID 4184834. 
  • COHEN, M, Creaven PJ, Fossieck BE Jr et al. Intensive chemotherapy of small cell bronchogenic carcinoma. Cancer Treatment Reports. 1977, s. 349–354. PMID 194691. 

profiles.nlm.nih.gov

  • US Department of Health Education and Welfare. Smoking and health: report of the advisory committee to the Surgeon General of the Public Health Service [online]. Washington, DC: US Government Printing Office, 1964. Dostupné online. 

obpr.gov.au

  • National Health and Medical Research Council. The health effects and regulation of passive smoking. www.obpr.gov.au. Australian Government Publishing Service, April 1994. Dostupné v archivu pořízeném z originálu dne September 29, 2007.  Archivovaná kopie. www.obpr.gov.au [online]. [cit. 2009-10-14]. Dostupné v archivu pořízeném z originálu dne 2007-09-29. 

ojrd.com

ox.ac.uk

ctsu.ox.ac.uk

  • PETO, R, Lopez AD, Boreham J et al. Mortality from smoking in developed countries 1950–2000: Indirect estimates from National Vital Statistics. [s.l.]: Oxford University Press, 2006. Dostupné online. ISBN 0-19-262535-7. 

oxfordjournals.org

ije.oxfordjournals.org

  • TAYLOR, R, Najafi F, Dobson A. Meta-analysis of studies of passive smoking and lung cancer: effects of study type and continent. International Journal of Epidemiology. 2007, s. 1048–1059. Dostupné online. DOI 10.1093/ije/dym158. PMID 17690135. 
  • CHARLOUX, A, Quoix E, Wolkove N et al. The increasing incidence of lung adenocarcinoma: reality or artefact? A review of the epidemiology of lung adenocarcinoma. International Journal of Epidemiology. 1997, s. 14–23. Dostupné online. DOI 10.1093/ije/26.1.14. PMID 9126499. 

annonc.oxfordjournals.org

jnci.oxfordjournals.org

  • PALMARINI, M, Fan H. Retrovirus-induced ovine pulmonary adenocarcinoma, an animal model for lung cancer. Journal of the National Cancer Institute. Oxford University Press, November 2001, roč. 93, čís. 21, s. 1603–1614. Dostupné online. DOI 10.1093/jnci/93.21.1603. PMID 11698564. 

toxsci.oxfordjournals.org

rsnajnls.org

radiographics.rsnajnls.org

  • SEO, JB, Im JG, Goo JM et al. Atypical pulmonary metastases: spectrum of radiologic findings. Radiographics. 1 March 2001, s. 403–417. Dostupné online. PMID 11259704. 

smokinglungs.com

  • GRANNIS, FW. History of cigarette smoking and lung cancer [online]. smokinglungs.com [cit. 2007-08-06]. Dostupné v archivu pořízeném z originálu dne 2007-07-18. 

un.org

  • United Nations News service: UN health agency calls for total ban on tobacco advertising to protect young, tisková zpráva, [cit. {{{accessdate}}}], Dostupné on-line.

vpci.org.in

  • BEHERA, D, Balamugesh T. Lung cancer in India. Indian Journal of Chest Diseases and Allied Sciences. 2004, s. 269–281. Dostupné online. PMID 15515828. 

web.archive.org

  • O'REILLY, KM, Mclaughlin AM, Beckett WS, Sime PJ. Asbestos-related lung disease. American Family Physician. 2007, s. 683–688. Dostupné v archivu pořízeném dne 2007-09-29. PMID 17375514. 
  • Carmona, RH. The Health Consequences of Involuntary Exposure to Tobacco Smoke: A Report of the Surgeon General [online]. U.S. Department of Health and Human Services, 2006-06-27 [cit. 2009-10-14]. Dostupné v archivu pořízeném dne 2006-07-03. 
  • COLLINS, LG, Haines C, Perkel R, Enck RE. Lung cancer: diagnosis and management. American Family Physician. American Academy of Family Physicians, January 2007, roč. 75, čís. 1, s. 56–63. Dostupné v archivu pořízeném dne 2007-09-29. PMID 17225705.  Archivováno 29. 9. 2007 na Wayback Machine.
  • ALBERG, AJ, Samet JM. Epidemiology of lung cancer. Chest. American College of Chest Physicians, 2007, s. 29S–55S. Dostupné v archivu pořízeném dne 2020-03-29. DOI 10.1378/chest.07-1347. PMID 17873159. 
  • National Health and Medical Research Council. The health effects and regulation of passive smoking. www.obpr.gov.au. Australian Government Publishing Service, April 1994. Dostupné v archivu pořízeném z originálu dne September 29, 2007.  Archivovaná kopie. www.obpr.gov.au [online]. [cit. 2009-10-14]. Dostupné v archivu pořízeném z originálu dne 2007-09-29. 
  • World Health Organization: Outdoor Air Pollution Causes Cancer. www.cancer.org [online]. [cit. 2015-03-13]. Dostupné v archivu pořízeném z originálu dne 2015-03-04. 
  • COGLIANO, VJ, Baan, R; Straif, K; Grosse, Y; Lauby-Secretan, B; El Ghissassi, F; Bouvard, V; Benbrahim-Tallaa, L; Guha, N; Freeman, C; Galichet, L; Wild, CP. Preventable exposures associated with human cancers.. Journal of the National Cancer Institute. 2011 Dec 21, s. 1827-39. Dostupné v archivu pořízeném dne 2012-09-20. PMID 22158127.  Archivovaná kopie. monographs.iarc.fr [online]. [cit. 2014-07-31]. Dostupné v archivu pořízeném z originálu dne 2012-09-20. 
  • PORT Meta-analysis Trialists Group. Postoperative radiotherapy for non-small cell lung cancer. Redakce Rydzewska Larysa. Cochrane Database of Systematic Reviews. 2005, s. CD002142. Dostupné online. DOI 10.1002/14651858.CD002142.pub2. PMID 15846628.  Archivovaná kopie. mrw.interscience.wiley.com [online]. [cit. 2009-10-14]. Dostupné v archivu pořízeném z originálu dne 2010-02-09. 
  • GRANNIS, FW. History of cigarette smoking and lung cancer [online]. smokinglungs.com [cit. 2007-08-06]. Dostupné v archivu pořízeném z originálu dne 2007-07-18. 

who.int

  • WHO. Cancer [online]. World Health Organization, February 2006 [cit. 2007-06-25]. Dostupné online. 
  • Frequently asked questions about second hand smoke [online]. [cit. 2012-07-25]. Dostupné online. 
  • WHO Disease and injury country estimates [online]. 2009 [cit. 2009-11-11]. Dostupné online. 
  • Gender in lung cancer and smoking research [online]. World Health Organization, 2004 [cit. 2007-05-26]. Dostupné online. 

wiley.com

onlinelibrary.wiley.com

  • FERLAY, J, Shin HR, Bray F et al. Estimates of worldwide burden of cancer in 2008: GLOBOCAN 2008. International Journal of Cancer. December 2010, s. 2893–2917. Dostupné online. DOI 10.1002/ijc.25516. PMID 21351269. 
  • BIESALSKI, HK, Bueno de Mesquita B, Chesson A et al. European Consensus Statement on Lung Cancer: risk factors and prevention. Lung Cancer Panel. CA Cancer J Clin. Smoking is the major risk factor, accounting for about 90% of lung cancer incidence.: 1998, s. 167–176; discussion 164–166. Dostupné online. DOI 10.3322/canjclin.48.3.167. PMID 9594919. 
  • MANSER, RL, Irving LB, Stone C et al. Screening for lung cancer. Cochrane Database of Systematic Reviews. 2004, s. CD001991. Dostupné online. DOI 10.1002/14651858.CD001991.pub2. PMID 14973979. 

mrw.interscience.wiley.com

worldcat.org

  • Adler, I. Primary Malignant Growths of the Lungs and Bronchi. New York: Longmans, Green, and Company, 1912. OCLC 14783544 , cited in Spiro SG, Silvestri GA. One hundred years of lung cancer. American Journal of Respiratory and Critical Care Medicine. 2005, s. 523–529. DOI 10.1164/rccm.200504-531OE. PMID 15961694.